Author

J. William Langston

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:Bayesian inference· 1 Research Focus:differential expression· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Birgitt SchüleiD· 2 shared Alexis BriceiD· 1 shared Ali Samii· 1 shared Allison KlotziD· 1 shared Anat MirelmaniD· 1 shared Anthony Edward LangiD· 1 shared Arcan GüveniD· 1 shared Avi Orr‐UrtregeriD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Birgitt SchüleORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification and Validation of N-Acetylputrescine in Combination With Non-Canonical Clinical Features As a Parkinsons Disease Biomarker Panel

Kuan‐Wei Peng, Allison Klotz, Arcan Güven, Unnati Kapadnis, Shobha Ravipaty, Vladimir Tolstikov, Vijetha Vemulapalli, Leonardo O. Rodrigues, Hongyan Li, Mark D. Kellogg, Farah Kausar, Linda Rees, Rangaprasad Sarangarajan, Birgitt Schüle, J. William Langston, , Michael A. Kiebish

The paper identifies and validates a biomarker panel combining N-acetylputrescine with clinical features for Parkinson's disease diagnosis, showing high diagnostic accuracy.

Scientific Reports · May 1, 2024Peer-reviewedNeuroscience

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease

Dongbing Lai, Babak Alipanahi, Pierre Fontanillas, Tae-Hwi Linus Schwantes-An, Jan Olav Aasly, Roy N. Alcalay, Gary W. Beecham, Daniela Berg, Susan Bressman, Alexis Brice, Kathrin Brockmann, Lorraine N. Clark, Mark Cookson, Sayantan Das, Vivianna M. Van Deerlin, , Tatiana Foroud

This study identifies genetic modifiers of LRRK2 mutations in Parkinson's disease, finding a significant variant in CORO1C and a polygenic risk score effect on penetrance.

Annals of Neurology · May 3, 2021Peer-reviewedGenetic & Genomic Medicine